Drug intelligence / Profile preview

dactylis glomerata allergen extract

Development stage
Approved
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous, Intradermal, Subcutaneous
01

Overview

Dactylis glomerata allergen extract, derived from Orchard grass pollen, is a biological product used for the diagnosis and treatment of allergies to this specific grass. For diagnosis, it is administered via skin prick or intradermal tests to elicit a localized IgE-mediated allergic reaction (a wheal-and-flare response) in sensitized individuals. As a therapeutic, it is used in allergen immunotherapy (also known as hyposensitization or allergy shots) to reduce allergic symptoms such as rhinitis and conjunctivitis. This treatment involves administering gradually increasing doses of the extract to induce immune tolerance, which is thought to involve a shift from a Th2-mediated allergic response to a more balanced response with the induction of regulatory T cells and allergen-specific IgG4 blocking antibodies. Clinical studies have also utilized this extract as a controlled challenge agent to investigate the mechanisms of allergic diseases, such as the exacerbation of atopic dermatitis upon environmental exposure.

Brand names
Oralair
Other names
dactylis glomerata pollenOrchard grass pollen extractStandardized Orchard Grass Pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on dactylis glomerata allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dactylis glomerata allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call